A complete application in a minute
Tailored resume and cover letter, ready to send.
Ambry Genetics Corporation seeks a Technical Product Manager to lead software lifecycle efforts for Genomic Tertiary Analysis and Reporting tools. You will define system requirements, write user stories, and drive SDLC activities from discovery to validation, bridging clinical genetics with software engineering to empower variant interpretation and final report generation.
You will collaborate with integration engineering, QA, and stakeholders to ensure timely delivery and alignment with
Compensation: US Range: $85,000 - $115,000
Role Overview: As a Technical Product Manager working with the Integration Engineering team, you will analyze and define system requirements to support the software products in the clinical genetics domain area. The TPM will oversee the software enhancements through the entire SDLC, from discovery, design, development, and validation. The TPM is responsible for communicating technical and functional requirements with stakeholders and users, creating Jira tickets detailing requirements for the scrum teams, overseeing the deliverable timeline to be met, and reporting project status updates upon request. You will have the opportunity to create innovative solutions and leverage the latest technologies to make our diagnostics-testing even better. For this role, we are seeking a domain-expert to own and drive the software product lifecycle for our Genomic Tertiary Analysis and Reporting applications. The ideal candidate will bridge the gaps between complex clinical genetics, bioinformatics pipelines, and software engineering. You will be primarily responsible for the vision, intake, and execution of tools that ingest processed genomic data and empower clinical scientists to perform variant interpretation, clinical curation, and final report generation. The ideal candidate possesses a rare blend of deep technical software management skills and a strong foundational understanding of clinical variant analysis.
To review Ambry’s Privacy Notice, Click here: https://www.ambrygen.com/legal/privacy-policy
To review the California privacy notice, click here: California Privacy Notice | Ambry Genetics
To review the UKG privacy notice, click here: California Privacy Notice | UKG
Equal Opportunity Employer This employer is required to notify all applicants of their rights pursuant to federal employment laws. For further information, please review the Know Your Rights notice from the Department of Labor.
Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics. We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives. We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankind has ever faced. Head on.